T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Digi International
DGII
$3.23B
| $627K | ﹤0.01% |
18,121
-11,116
| -38% | -$345K |
|
|
HPP
2002
Hudson Pacific Properties
HPP
$777M
| $626K | ﹤0.01% |
8,162
+1,041
| +15% | +$101K |
|
2003
Arcus Biosciences
RCUS
$3.67B
| $626K | ﹤0.01% |
23,899
+6,198
| +35% | +$164K |
|
|
OPTU
2004
Optimum Communications Inc
OPTU
$227M
| $625K | ﹤0.01% |
107,084
+18,019
| +20% | +$173K |
|
2005
Schrodinger
SDGR
$1.38B
| $624K | ﹤0.01% |
24,975
+6,927
| +38% | +$204K |
|
|
BBBY
2006
Bed Bath & Beyond
BBBY
$403M
| $620K | ﹤0.01% |
27,969
+1,880
| +7% | +$47.1K |
|
2007
TG Therapeutics
TGTX
$7.58B
| $620K | ﹤0.01% |
104,583
+4,326
| +4% | +$28.4K |
|
2008
Center Bancorp
CNOB
$1.81B
| $619K | ﹤0.01% |
26,803
+6,256
| +30% | +$160K |
|
2009
Northern Oil and Gas
NOG
$2.57B
| $616K | ﹤0.01% |
22,464
+5,736
| +34% | +$162K |
|
2010
Dave & Buster's
PLAY
$361M
| $616K | ﹤0.01% |
19,846
-4,151
| -17% | -$155K |
|
|
B
2011
DELISTED
Barnes Group Inc.
B
| $615K | ﹤0.01% |
21,292
-16,314
| -43% | -$523K |
|
2012
The Honest Company
HNST
$540M
| $614K | ﹤0.01% |
175,219
-221,213
| -56% | -$812K |
|
2013
Hain Celestial
HAIN
$52.9M
| $613K | ﹤0.01% |
36,285
-466,981
| -93% | -$10M |
|
|
CBAY
2014
DELISTED
Cymabay Therapeutics
CBAY
| $613K | ﹤0.01% |
175,100
+52,900
| +43% | +$190K |
|
|
PRO
2015
DELISTED
PROS Holdings
PRO
| $611K | ﹤0.01% |
24,716
+3,905
| +19% | +$94.7K |
|
2016
XPEL
XPEL
$1.35B
| $611K | ﹤0.01% |
9,477
+1,423
| +18% | +$92.4K |
|
2017
Globalstar
GSAT
$10.8B
| $609K | ﹤0.01% |
25,495
-27,211
| -52% | -$656K |
|
2018
Worthington Enterprises
WOR
$2.78B
| $603K | ﹤0.01% |
25,637
+4,733
| +23% | +$145K |
|
|
HT
2019
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $603K | ﹤0.01% |
75,498
-39,293
| -34% | -$392K |
|
|
PRPC
2020
DELISTED
CC Neuberger Principal Holdings III
PRPC
| $603K | ﹤0.01% |
60,625
| – | – |
|
2021
M/I Homes
MHO
$3.82B
| $602K | ﹤0.01% |
16,607
+2,315
| +16% | +$100K |
|
2022
Piper Sandler
PIPR
$5.34B
| $602K | ﹤0.01% |
22,988
-16,520
| -42% | -$481K |
|
2023
Transocean
RIG
$6.39B
| $602K | ﹤0.01% |
243,720
+34,500
| +16% | +$110K |
|
2024
Empire State Realty Trust
ESRT
$817M
| $601K | ﹤0.01% |
91,586
+8,356
| +10% | +$62K |
|
|
HEES
2025
DELISTED
H&E Equipment Services
HEES
| $600K | ﹤0.01% |
21,141
+251
| +1% | +$7.9K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.